Mechanisms and therapeutic applications of electromagnetic therapy in Parkinson's disease

Behavioral and Brain Functions : BBF
Maria VadalàTommaso Iannitti

Abstract

Electromagnetic therapy is a non-invasive and safe approach for the management of several pathological conditions including neurodegenerative diseases. Parkinson's disease is a neurodegenerative pathology caused by abnormal degeneration of dopaminergic neurons in the ventral tegmental area and substantia nigra pars compacta in the midbrain resulting in damage to the basal ganglia. Electromagnetic therapy has been extensively used in the clinical setting in the form of transcranial magnetic stimulation, repetitive transcranial magnetic stimulation, high-frequency transcranial magnetic stimulation and pulsed electromagnetic field therapy which can also be used in the domestic setting. In this review, we discuss the mechanisms and therapeutic applications of electromagnetic therapy to alleviate motor and non-motor deficits that characterize Parkinson's disease.

References

Sep 1, 1992·The International Journal of Neuroscience·R Sandyk
Aug 1, 1991·Electroencephalography and Clinical Neurophysiology·P FuhrM Hallett
Jan 1, 1991·Movement Disorders : Official Journal of the Movement Disorder Society·T Z AzizA R Crossman
Jan 1, 1990·Movement Disorders : Official Journal of the Movement Disorder Society·S A FactorW J Weiner
Jun 1, 1989·Journal of Neurology, Neurosurgery, and Psychiatry·A J Lees
May 11, 1985·Lancet·A T BarkerI L Freeston
Dec 1, 1988·Clinical Neuropharmacology·A J LeesV L Campbell
Oct 1, 1994·Electroencephalography and Clinical Neurophysiology·D Rudiak, E Marg
Nov 1, 1994·The International Journal of Neuroscience·R Sandyk
Aug 1, 1994·Brain : a Journal of Neurology·A Pascual-LeoneM Hallett
Oct 1, 1996·Electroencephalography and Clinical Neurophysiology·E M WassermannM Hallett
Jan 1, 1997·Journal of Neural Transmission·D Ben-ShacharE Klein
Jun 1, 1997·The International Journal of Neuroscience·R Sandyk
Nov 5, 1997·Trends in Pharmacological Sciences·P J RichardsonP G Jenner
Apr 1, 1997·The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy·T L RichardsC A Cunningham
Jan 5, 1999·Neurochemistry International·M MorariL Beani
Aug 31, 1999·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·A Pascual-LeoneJ P Keenan
Jul 25, 2000·Journal of Ethnopharmacology·M Sai RamW Selvamurthy
Dec 29, 2000·Depression and Anxiety·N N BoutrosR Ilmoniemi
Feb 13, 2001·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·L S BoylanH A Sackeim
Feb 22, 2001·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·M E KeckM Engelmann

❮ Previous
Next ❯

Citations

Jan 24, 2020·The Journal of Chemical Physics·N TodorovaI Yarovsky
Nov 22, 2019·Journal of Lasers in Medical Sciences·Nesrin Afify AbdulrashidAhmed Mamdouh AbdelKader
Feb 13, 2021·International Journal of Molecular Sciences·Aleksandra CiosŁukasz Szymański
Aug 15, 2021·Drug Metabolism and Personalized Therapy·Taiwo G Olubodun-ObadunOlufunmilayo O Adeyemi

❮ Previous
Next ❯

Methods Mentioned

BETA
SMAs
SMA

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Amygdala and Midbrain Dopamine

The midbrain dopamine system is widely studied for its involvement in emotional and motivational behavior. Some of these neurons receive information from the amygdala and project throughout the cortex. When the circuit and transmission of dopamine is disrupted symptoms may present. Here is the latest research on the amygdala and midbrain dopamine.

Basal ganglia in Parkinson's disease (MDS)

The basal ganglia is comprised of the neostriatum, the external and internal pallidal segments, the subthalamic nucleus, the substantia nigra pars reticulata, and the pars compacta of the substantia nigra. The basal ganglia circuitry is responsible for the correct execution of voluntary movements and is implicated in Parkinson's disease. Here is the latest research investigating the basal ganglia in Parkinson's disease.

Cajal Bodies & Gems

Cajal bodies or coiled bodies are dense foci of coilin protein. Gemini of Cajal bodies, or gems, are microscopically similar to Cajal bodies. It is believed that Cajal bodies play important roles in RNA processing while gems assist the Cajal bodies. Find the latest research on Cajal bodies and gems here.

Related Papers

The Australian and New Zealand Journal of Psychiatry
Patrick ClarkeCherrie Galletly
Cellular and Molecular Life Sciences : CMLS
N Prakash, W Wurst
Brain and nerve = Shinkei kenkyū no shinpo
Hideaki Matsui, Ryosuke Takahashi
© 2021 Meta ULC. All rights reserved